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Summary
Infection of sensitive adult mice with myeloproliferative sarcoma virus (MPSV) results in a
myeloproliferative syndrome. Two components of the viral genome are required to induce this
unique pathology: the mos oncogene and sequences within the U3 region of the long terminal
repeat (LTR). In studies designed to identify the target cell of MPSV and thus better understand
the mechanism by which a myeloproliferative syndrome is induced, we have infected a series
of T cell lines with MPSVbased vectors. The results presented here show that infection with
neon MPSV abrogates the requirement for an antigen-specific or feeder cell-dependent stim-
ulation, without altering the requirement for interleukin 2. Significantly, this response is not
dependent on the mos oncogene, but requires sequences within the U3 region of the MPSV
LTR. No alteration in the constitutive or induced levels of lymphokines released by these cells
was observed. These results suggest a model in which T cells acquire a proliferative advantage
by uncouplingthe proliferative response from the lymphokine synthesis that is induced by activation
of the T cell receptor. These cells are thus poised for antigen stimulation and secretion ofcytokines
that stimulate myelopoiesis.
T
he myeloproliferative sarcoma virus (MPSV)', a mem-
ber of the Moloney murine sarcoma virus (Mo-MuSV)
family, differs from all other members of this mos-oncogenc
virus family by its distinct ability to induce a myeloprolifera-
tive disease in adult Mpsv, mice (1, 2). Recombinant viruses
between MPSV and Mo-MuSV have demonstrated that the
pathology induced by MPSV requires both the mos oncogene
and unique sequences within the MPSV U3 region of the
long terminal repeat (LTR) (3, 4). In addition, results ob-
tained from comparing the efficiency of expression of MPSV
and Moloney murine leukemia virus (MuLV)-derived vectors
in hemopoietic precursor (5) and stem cell lines(Beck-Engeser,
G. et al., manuscript submitted for publication), lymphoid
precursor cells (6), liver cells (7), and the embryonic carci-
noma cell lines F9 (8) and PCC4 (9) have established that
the MPSV LTR is a more effective transcriptional promoter
'Abbreviations used in this paper . CM, conditioned medium; GM-CSF,
granulocyte/macrophage-CSF; GTU, G-418 resistance transfer units;
LTR, long terminal repeat; MOI, multiplicity of infection; Mo-MuSV,
Moloney murine sarcoma virus; MPSU, myeloproliferative sarcoma vi-
rus; MuLV Moloney murine leukemia virus; SN, supernatant.
than the Mo-MuLV LTR in these cells. The myeloprolifera-
tive disease induced by MPSV is thus most likely a conse-
quence of relatively high levels of mos expression in a specific
target cell(s). The target cell for the MPSVinduced my-
eloproliferative disease has, however, remained elusive.
MPSV infection of adult Mpsv' mice generates a large in-
crease (in some cases >100-fold) in hematopoietic precursor
cells, including all cells of the myeloid lineage (eosinophils,
megakaryocytes, erythroid, and macrophage-granulocyte
precursors) and a large increase in myeloid stem cells as mea-
sured by spleen colony formation (CFU-S), and by mixed
colony assays (10, 11). Two alternative explanations for the
large increase in precursor cells in MPSVinfected animals have
been proposed (1, 12). The simplest interpretation would be
that all ofthe infected precursor cells have gained a prolifera-
tive advantage as a consequence of increased expression of
the mos oncogene. However, when established hematopoi-
etic multipotent and precursor cell lines (e.g., FDC-Pmix and
FDC-PI) were infected with MPSV, and their proliferation
and relative growth factor response monitored, no significant
differences in growth kinetics or factor requirements were
observed, as compared with uninfected controls (5, and un-
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for the viral-induced myeloproliferation has been proposed
based on the observation that spleens from infected mice re-
lease a growth factor or CSF that stimulates myeloid precursor
cells, and thus couldaccount for the myeloproliferation (13).
Support for this alternative has also been provided by experi-
ments using a mutant of the MPSV, in which the transforming
function of the mos oncogene is temperature sensitive (14).
Spleen cell-conditioned media (CM) from MPSVinfected mice
sustained erythro- and myelopoiesis in vitro only if prepared
under permissive conditions for the mos oncogene (15) . The
disease couldthus be due to increased CSF release, as has been
described in mice injected with multipotent hematopoietic
cells expressing 11,3 or granulocyte/macrophage (GM)-CSF
via a retroviral vector (16, 17).
As lymphocytes are one of the major sources of growth
factors, they are a potential target for the action of MPSV
CD4* lymphocytes release a broad variety of lymphokines
acting on the immune response as well as on myelopoiesis
(e.g., IL3, GM-CSF, IL4, IL5, IL6). However, production
of lymphokines requires either prior activation via the TCR
by antigen presentation or by antibodies that recognize the
Ti or CD3 components of the TCR complex (18). Lectins
like Con A can activate T cells by binding polyvalently to
the TCR, and thus are functionally equivalent to antigen and
antiTCR antibodies (19).
In this work, we wanted to analyze the effect of MPSV
infection on lymphocytes with regard to growth requirements
and cytokine production. Three murine T cell lines with
different requirements for continued growth were used as
model populations: S491G3 cells (20), LB3 (21), and E9.D4
(22) . The E9.D4 cell line requires both IL-2 and TCR activa-
tion by a specific hapten-la complex for a mitogenic response.
The LB3 cell line also has a strict requirement for two stimuli
for proliferation: IL-2, and a stimulus presented to the cell
via spleen filler cells. The nature of the spleen filler cells re-
quired for the maintenance of both T cell lines E9.D4 and
LB3 is unknown. Although the LB3 cell line was derived
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from a primary BALB/c anti-DBA/2 MLC, LB3 cells have
been shown to be ofDBA/2 origin (own unpublished results),
and thus, the mechanism ofactivation by the syngeneic spleen
cells is unknown. The third cell line, S491G3 lymphoma, is
neither 11,2 dependent nor requires filler cells for prolifera-
tion. All lines can be induced to express several cytokines that
stimulate myelopoiesis (23, 24).
In this study, we focused on the putative transforming
potential of MPSV on T cells after infection by investigating:
(a) IL2 requirement for growth; (b) requirement for stimu-
lation by antigen or by an undefined soluble factor; and (c)
lymphokine production. Three types of vectors were used
to test separately the role of the mos oncogene and of the
unique transcriptional control region of MPSV.
Materials and Methods
Cell Lines.
￿
All T cell lines and the myeloma cell line NSO were
maintained in modified DMEM, L-glutamine, and 5-10% heat-
inactivated FCS (T cell medium). Supernatant (SN) (2-5%) of the
phorbol ester (PMA)-induced EL4 thymoma cell line was used as
a source ofIL2 (25). LB3 and E9.D4 cells were cultured by weekly
passage with 3,000-rad irradiated spleen cells (DBA/2 and azo-
benzenearsonate-coupled CBA cells, respectively) as described (21,
22). Virus-producing cell lines were kept in modified MEM, L-
glutamine (216 mg/liter), and 10% heat-inactivated FCS (27) . All
incubations were carried out at 37°C in a humidified atmosphere
of 5% COZ in air.
ViralInfections.
￿
Infectious viruswas collected as a 12-h SN from
virus-producing *2 cells (27) and filtered through prewashed 0.8-
gm filters (Millipore Continental Water Systems, Bedford, MA).
To assay for infectious virus particles, triplicate cultures of 103
NIH/3T3 fibroblasts/well were exposed to 1:5 serial dilutions of
virus-containing SN . SN was removed after 24 h, and virus-infected
cells were selected with medium containing 400 ug/ml Geneticin
(G-418) and scored after 2 wk. The number ofG-418-resistant colo-
nies obtained at end-point dilution was used to calculate the G-418
resistance transfer units (GTU)/ml.
Lymphoid cell lines were infected by exposure to cell-free SN
from virus-producing *2 cells supplemented with 11,2. After a
6-h incubation period, cells were washed two times, cultured in
Figure 1.
￿
Vectors used for infections. Construction
of neon MPSV and neon/mos- have been previously
described (3). Note that the residual mos sequences of
neoA/mos- potentially encode a 59-residue peptide
sharing only 29 NHZ-terminal amino acids with the
300-residue mos protein, but no transforming activity
mos
￿
3'LTR
￿
in either in vitro or in vivo assays has been demon-
strated. MOV/mos- was constructed by replacing a
Clal x Bg1II fragment containing the 3'MPSV LTR
from neon/MOs- with a similar fragment containing
the 3'Mo-MuLV LTR (cl MOV3; 47, and M. Grez,
omos -
￿
unpublished results). A 1.2-kb HindIll fragment con-
taining residual mos and pol sequences was also
deleted. After one round of replication, this vector is
composed of chimeric LTRs, with the U3 region
being derived from Mo-MuLV (indicated by a shaded
box). Restriction enzymes used for vector construc-
tion and Southern analysis are abbreviated as follows:
S, Sstl; B, BamHI; and H, HindIII . SA, splice
1 kb
￿
donor; s.a., splice acceptor for the mos transcript.
S
s
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tion in 96-well plates either with or without 1 mg/ml G-418. Cell
concentrations plated ranged from 0.2 to 5 cells/wellfor uninfected
control cells and 50 to 1,000 cells/wellfor infected cells. 2 wk after
plating, positive wells were scored. Cloning efficiency was calcu-
lated by Poisson distribution analysis.
ReplicaPlating Assay.
￿
Half the media and cells (100 pl) of posi-
tive wells from primary infection plates was transferred into 96-
well plates and supplemented with T cell medium containing 20%
FCS, 4-10% EL4 SN, and where indicated, 2 mg/ml G-418 . Filler
cells were not added as a stimulus. Transfer of positive wells was
carried out once a week.
IL-2-dependent Proliferation Assay.
￿
Cellswere washed three times
before a 48-h incubation with 1:3.15 serial dilutions of EL4 SN
as a source of 11,2 in 96-well plates (104 cells/well). After a 6-h
pulse with 0.5 t&Ci [;H]thymidine/well, triplicate cultures were
harvested onto glass fiber filters with an automatic cell harvester
(Skatron, Norway). Incorporated radioactivity was measured by
scintillation spectrometry. The 11,2-dependent T cell line CTLL
was used as standard control.
CSFProduction Assay.
￿
Cells were washed three times and cul-
tured at 5 x 105 cells/ml with or without anti-CD3 antibody
(145-2C11) adsorbed to culture wells as a 10-pg/ml solution in PBS
as previously described (24). After 48 h of incubation, CM were
harvested and assayed for GM-CSF activity on FDC-P1 and FDC-
P2 or 32D cells (2 x 103 cells/well) by [3H]thymidine incorpora-
tion. Mouse lung cell CM (2.5 x 104 U/ml) or rIL3 (1 ng/ml
= 320 U/ml) were used as internal standards.
RNA and DNAAnalysis.
￿
Genomic DNA was isolatedby stan-
dard techniques, and restriction enzyme digestionswere performed
as recommended by the suppliers. Digested DNA was separated
on agarose gels and transferred to GeneScreen Plus (New England
Nuclear, Boston, MA) membrane filters. Total RNA was isolated
by the procedure of Auffray and Rougeon (28), denatured with
glyoxal and dimethylsulfoxide, and subjected to electrophoresis
through an agarose gel (29) before transfer to membrane filters.
DNA or RNA immobilized on filters were hybridized with DNA
fragments labeled by the method of Feinberg and Vogelstein (30) .
Probes used for analysis included mos- and neo-specific sequences
previously described (3).
Table 1.
￿
Transfer Efficiency ofMPSV-based Vectors into Fibroblasts and Lymphoid Cells
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Results
Equal Transfer Efficiencies ofMPSV- and Mo-MuLVderived
Vectors into Lymphoid Cell Lines. We first sought to deter-
mine if the different lymphoid cell lines could be effectively
infected and if any difference in infection efficiency could be
seen between several vectors. Three MPSVbasedvectors con-
taining the neomycin phosphotransferase gene (neon) as a
dominant selectable marker were used for infection (Fig. 1).
neoRMPSV is the wild-type vector with the intact mos on-
cogene, whereas in neon/mos- , the mos coding region has
been deleted. In a third construct the LTR U3 region of the
neon/mos- vector has been replaced with sequences of the
Mo-MuLV (MOV/mos - ). For general comparison, the Mo-
MuLVderived ZipneoR vector (31) was also included. The
ZipneoR and the MOV/mos - both have the Mo-MuLV U3
region, in contrast to the other two constructs, which have
MPSVderived LTRs.
Vectors were introduced into *2 packaging cells (27) to
produce virus particles that transfer only the replication-
defective vectors into the target cells. The two IIr2-dependent
CD4+ T cell lines, LB3 and E9.D4, as well as the thymoma
cell line S49IG3 and the myeloma cell line NSO, were used
as target cells for infection with MPSV vectors.
As shown in Table 1, neon transfer (GTU) of MPSV into
all of the lymphoid cells was two or three orders of magni-
tude lower than transfer into NIH/3T3 fibroblasts. The
transfer efficiencies of the two MPSV vectors, as compared
with the two vectors with Mo-MuLV LTR U3 regions (Zip-
neoR and MOV/mos - ), showed no significant differences.
Southern blot analysis was performed on DNA isolated
from infected cultures to verify the presence of an integrated
provirus. Digestions with Sstl and BamHI in combination
with neo- and mos-specific probes confirmed the presence of
an intact provirus (Figs. 1 and 2, and data not shown).
T Cell Lines Infected with MPSVAre Unaltered in Their Re-
quirementfor IL2.
￿
A model in which the paracrine stimula-
Cell line Viral vector
U3 Region
of the LTR
mos
Oncogene
Total
Fibroblasts
GTU/Exp.
Lymphoid cells
Ratio GTU
(lymphoid cells/fibroblasts)
LB3 neon MPSV MPSV + 1 .4x101 5 .5x103 3.9x10 -1
neon MPSV mos - MPSV - 1.8 x 104 4 .5 x 101 2.5 x 10 -2
neoR MOV/mos - Mo-MuLV - 3.4 x 103 1 .8 x 101 5.3 x 10-2
E9.D4 neon MPSV MPSV + 5.6x101 6 .7x101 1 .2x10 -3
neon MPSV mos - MPSV - 5.5 x 105 1 .1 x 103 2 x 10-3
MZip neo' Mo-MuLV - 6.3x103 7 .5x10' 1 .2x10 -1
S49IG3 neo' MPSV MPSV + 1.2x104 9 .7x101 8x10-1
neo' MPSV mos - MPSV - 1.6 x 106 5 .7 x 103 3.6 x 10 -3
NSO neo' MPSV MPSV + 4.8 x 104 7 .7 x 101 1 .6 x 10 -1
neo' MPSV MOs- MPSV - 1 .2 x 104 5 .1 x 101 4.3 x 10 -1Figure 2 .
￿
Southern analysis of infected LB3 cells . DNA of unin-
fected and infected LB3 cells and fibroblasts was digested with SstI
and BamHI and hybridized to a neon-specific probe. Lane 1, control,
uninfected LB3 ; lane 2, control, neon MPSV-infected fibroblast
cell line; lane 3, neon MPSV-infected LB3 cells ; lane 4, control,
neon/mos--infected fibroblast cell line; lane 5, neoP ,/mos - -infected
LB3 cells.
tion of the myeloid compartment of MPSVinfected mice
results in a myeloproliferative syndrome requires that there
be a constant source of factor-producing cells. This could be
provided by T lymphocytes that after infection with MPSV
either have acquired altered mitogenic requirements and thus
may be more readily induced to secrete growth factors or,
alternatively, constitutively release high levels ofgrowth factors
without induction .
Therefore, we first tested whetherLB3 or E9.D4 cells in-
fected with neoRMPSV acquired IL2-independent growth .
The IL2 requirement of infected LB3 and E9.D4 cells was
assayed by [3H]thymidine incorporation by proliferating cells
in the presence ofvarious dilutions of IL2 . Infected LB3 and
E9.D4 cells maintained identical requirements for IL-2 to unin-
fected cells (N50 U/ml) and showed no altered sensitivity
to IL2, regardless of whether mos+ or mos - vectors were
used for infection. Thus, neither the mos oncogene nor
retroviral infection alter the IL2 requirement of these estab-
lished T cell lines.
MPSV Infection Abrogates the Requirement of T Cell Lines
for Filler Cells and/or Antigen Stimulation oftheMR . Some
T cell lines periodically require a mitogenic stimulus provided
by appropriate filler cells to maintain long-term proliferation
450 T Cell Receptor Stimulation Abrogated by Retroviral Vectors
Table 2 .
￿
Clonability of MPSV-infected LB3 Cells as a
Function of Time after Stimulation
Percent cloning efficiency
at end-point dilution"
Virus
None
neon MPSV
nedi MPSV mos -
X=48±22
" Cloning efficiency was calculated by Poisson distribution .
Weeks after stimulation .
S Clones were obtained by recloning of virus-infected G418-resistant
mass cultures .
in vitro. This stimulus may be either triggered directly via
the TCR, as in the case of the hapten-specific antigen-
dependent E9.D4 cells, or alternatively, by anunknown mech-
anism, as in LB3 cells . Abrogation of this requirement by
the mos oncogene may be a mechanism by which MPSV
infected lymphocytes could acquire a selective growth advan-
tage in vivo. We therefore tested whether the altered growth
properties of the 11,2- and feeder cell-dependent LB3 cells
were altered after infection with neon MPSV Under op-
timal conditions (weekly exposure to irradiated spleen cells),
the cloning efficiency of the uninfected parental LB3 cell line
varied between 30 and40%, but decreased to 6% 4 wk after
the last stimulation; soon afterwards, the clone (or the cells)
became extinct (Table 2) . UninfectedLB3 mass cultures could
not be propagated for>12 wk without stimulation. In con-
trast, MPSVinfected LB3 cultures exhibited a cloning efficiency
of60% 10 wk after infection and 12 wk after the last stimu-
lation with filler cells (Table 2) . This cloning efficiency ex-
ceeds that of the uninfected parental LB3 cells maintained
under optimal conditions .
Clonal analysis of different infected subclones provides a
more definitive test to measure the relative growth advan-
tage and feeder independence of infected lymphocytes. Thus,
a second series of experiments was designed to analyze sev-
eral hundred clones . TheE9.D4 cell line was included in this
Clone no .
Bulk cultures
7$
1# 4 12
30-40 6 ND
59
8 100
9 59
11 40
12 39
X=60±25
1 69
2 75
3 39
4 27
5 30analysis to determine if MPSV infection would also lead to
abrogation of the requirement for antigenic stimulation. Cells
infected with a multiplicity of infection (MOI) of <1 were
plated in microtiter plates under G-418 selection at cell den-
sities that ensured the outgrowth of a single infected cell per
well, based on Poisson distribution analysis. The resulting
infected clones were grown to confluence and then diluted
1:2 for each serial passage in a second microtiter plate. Clonal
extinction of -500 clones each of uninfected and neon
MPSV-infected T cells was monitored over a several-month
period under identical growth conditions and comparable ini-
tial cell densities (Figs. 3 and 4) . The replica plating assay
was started 2 wk after infection and selection for virus-positive
(G-418 resistant) clones.
As shown in Fig. 3, the number of surviving uninfected
LB3 clones decreased dramatically during the first and second
platings to -20% of the original number of plated clones,
finally decreasing to <5% during the time course of the ex-
periment. Significantly, attempts to expand individual clones
after the sixth and seventh plating in search of spontaneous
of clones plated
100
50
0
Figure 3.
￿
Filler cell-independent growth of MPSVinfected LB3
cells. Replica plating assay of uninfected and infected LB3 clones. In-
fected clones were obtained from primary infection plates at end-
point dilution after 2 wk of G418 selection (1 mg/ml) for virus-
positive clones. Uninfected LB3 clones were obtained from control
experiments to determine cloning efficiency. Clones were maintained
in the presence of EL4 SN with (infected) or without (uninfected
clones) G418 and in the absence of filler cells. Plates were scored
weekly for proliferating clones, and half of the volume (100 pl) of
positive wells was transferred into new 96-well plates, where the total
volume was reconstituted with medium with 20% heat-inactivated
FCS, EL4 SN, and with or without 2 mg/ml G-418. Percent values
of clones plated were calculated from number of clones surviving 2
wk after infection and selection. Note that last exposure to filler cells
occurred 2 wk before infection. Uninfected LB3 clones (O, n =
550), neon MPSV-infected LB3 clones (", n = 541), neon MPSV
mos-infected LB3 clones (M, n = 541), neon MOV/mos - -infected
LB3 clones (" , n = 222). Arrows denote onset of cultivation stress,
when only 25% (50 pl) of the volume of positive wells was trans-
ferred.
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stimulation-independent mutants failed. The number of in-
fected G418-resistant clones dropped as well during the first
two platings, although to a lesser extent (60 and >40%,
respectively). Numbers of clones reached a plateau phase of
30-40% of the number of clones initially plated until more
stress was applied after the fifthreplating by transferring only
25% ofthe cellsinto new wells. Clone numbers were quickly
reduced to 5-10% of clones seeded at the starting point of
the experiment. Replica plating experiments with E9.D4 cells
(Fig. 4) were similar to those described for LB3, except that
no added stress was applied by replating fewer cells at any
passage. After 12 passages, a final plateau of 17% surviving
neon MPSV-infected E9.D4 was reached. These clones could
be replated for almost 1 yr (46 transfers), until termination
of the experiment.
As infected, but not uninfected, LB3 and E9.D4 cells were
selected in the presence of G-418 in the replica plating assay,
a control for a possible drug effect on cellular metabolism
and. doubling time was carried out. After the second pas-
sage, LB3 and E9.D4 clones selected in G-418 were passaged
into medium without G-418, and the remaining cells were
refed with selection medium. Virus-positive clones maintained
without G-418 displayed a pronounced improvement of sur-
vival (20% in LB3 clones, 12% in E9.D4 clones) over the
identical population maintained under selective pressure (Fig.
5) . G-418 selection, thus, does not augment but rather coun-
teracts the effect induced by MPSV infection.
Themos Oncogene ofMPSV Is notNecessaryforFiller Cell-de-
pendent Growth ofMPSV-infected T Cell Lines. Experiments
described in the previous section show that MPSV infection
abrogates the requirement for filler cells (LB3 cells) and also
for antigenTCR interaction (E9.D4 cells). Clonal analysis
% of clones
plated
100
50
0
weeks after
infection
13
￿
45 46
￿
no. of transfers
Figure 4.
￿
Filler cell-independent growth of MPSVinfected E9.D4
cells. Replica plating assay of uninfected and infected E9.D4 clones.
Experiment was carried out as described in Fig. 3. Uninfected E9.D4
clones (O, n = 611); neon MPSV-infected E9.D4 clones (A, n =
471); neoR MPSV mos --infected E9.D4 clones (A, n = 592); mZip
neoR-infected E9.D4 clones (", n = 87).of mass cultures and replica plating of individual clones in-
fected with the MPSV vector neoR/mos - lacking the on-
cogene were carried out to test whether the mos oncogent
was required for the abrogation of feeder dependence (Table
2 and Figs. 3 and 4). Results obtained from both mass cul-
ture and replica plating experiments of neoR/MoS --infected
LB3 or E9.D4 cells showed a similar acquisition offiller cell-in-
dependent growth, as compared with cells infected with
neoR MPSV The mos oncogene is thus not required for
abrogation of the requirement for filler cells.
To ascertain that infection with MPSV affects clonability
by interfering with the stimulation pathway, we infected the
stimulation-independent thymoma cell line S49IG3 with ei-
ther neoR MPSV or neoR/mos-. End-point dilution experi-
ments showed no enhancement in cloning efficiency after in-
fection, regardless of the virus used for infection (15-22%
both before and 5 wk after infection).
Filler Cell-independent Growth of MPSVinfected Cells Is a
Property ofthe MPSV LTR and not a Result ofRetroviral Infec-
tion. In previous work, we have pointed out that sequences
within the U3 component of the MPSV LTR play a crucial
role in the myeloproliferative disease (3, 4). To test the im-
portance of the U3 region in the abrogation of the stimula-
tion requirement, we infected LB3 and E9.D4 cells with
vectors (ZipneoR or MOV/mos -) that contain the U3 re-
Table 3.
￿
Lymphokine Production of MPSV-infected T Cell Lines
CM'
Virus
￿
Cell line
None
￿
LB3
E9.D4
S491G3
NeoR MPSV
￿
LB3 bulk culture
clones (n = 6)
E9 .D4 bulk cultures
(n=6)
S491G3 bulk culture
NeoR MPSV MOs-
￿
LB3 bulk culture
clones (n = 9)
129.134 bulk cultures
(n=6)
S491G3 bulk culture
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gion of the Mo-MuLV instead of MPSV LTR. Cells were
infected, and >200 neoR MOV/mos - LB3 clones and -100
ZipneoR-infected E9.D4 clones were selected and assayed by
replica plating (Figs. 3 and 4). MOV/mos -. and ZipneoR
clones were noticeably smaller at the time ofplating, as com-
pared with control neoR/mos --infected clones, and total
number of clones was dramatically reduced after the first
transfer, resulting in <1% of the original number by the
fourth and sixth transfer, respectively. Furthermore, no stable
clones from either infection couldbe maintained in culture.
No significant difference in proliferation of clones infected
with ZipneoR or MOV/mos -, as compared with uninfected
clones, was observed.
The marked difference in growth patterns of lymphocytes
infected with virus containing either the MPSV or the Mo-
MuLV LTR shows that the abrogation of filler cells and/or
requirement for TCR stimulation is a property only of the
vectors with an MPSV transcriptional control domain.
Lymphokine Production in T Cells Is not Altered afterMPSV
Infection. Do MPSVinfected lymphocytes release growth
factors spontaneously or do they show alterations in growth
factor induction that could account for a potential paracrine
stimulation of myeloid cells in vivo? CM from uninfected
and neoR MPSV- or neoR/mos --infected LB3, E9.D4, and
S49IG3 cells were collected from either unstimulated or Con
CSF activity
Unstimulated5
￿
Stimulatedll
U/ml
104
20±11
￿
9x104 ±1.4x 104
0
￿
ND
CM was harvested after 48-h incubation of 5 x 105/ml washed cells, 5--10 wk after infection.
# CSF activity was measured on FDC-P1 cells by [3H]thymidine incorporation. 50 U/ml is defined as the CSF activity that produces half-
maximal stimulation of colony-forming cells in normal bone marrow. Internal standards of either mouse lung cell CM or rIL-3 was used for
assays of LB3 and E9.D4 cells, respectively.
$ CSF activity of unstimulated cells vary -10-fold from assay to assay depending on the timepoint of last exposure to filler cells (1-3 wk) be-
fore the experiment.
II Stimulation with either Con A (10 ng/ml) for LB3 or anti-TCR mAb 145-2C11 (5 p,g/well, plastic-adsorbed) for 119.134 cells.
29-250
160
5 x 103
7.5 x 105
0 ND
280 104
222 ± 125 ND
39 ± 17 5.9 x 104 ± 1.2 x
0 ND
250 104
725 ± 715 NDA/anti-TCR-stimulated cells and tested for lymphokine pro-
duction (Table 3). CSF activity in SNs from unstimulated,
uninfected LB3 cells varied up to 10-fold, depending at which
time point after last exposure to spleen filler cells (1-3 wk)
the experiment was done. SNs from unstimulated MPSV
infected LB3 cells prepared 5-10 wk after infection showed
a basal CSF activity within the same order of magnitude.
CSF activity in CM from uninfected E9.D4 cells 1 wk after
stimulation exceeded by four- to eightfold the activity de-
tected in unstimulated, infected E9.D4 cells. Apparent differ-
ences were therefore not considered significant.
In addition, Con A or anti-TCR antibody stimulation of
the infected T cell lines was not altered compared with the
uninfected control. Uninfected controls, as well as infected
LB3 and E9.D4 cells, showed a similar 50-5,000-fold increase
in factor production of GM-CSF (Table 3) and similar levels
of expression of IIr3 (data not shown), as previously described
for uninfected LB3 and E9.D4 cells (23, 24).
Discussion
Release of growth factors that stimulate the hematopoi-
etic cells of the myeloid compartment has been observed as
a consequence of MPSV infection of adult mice and may be
responsible for the myeloproliferative disease induced by MPSV
(13, 14). Although several studies have concurred that prop-
erties of the LTR U3 region of MPSV, in addition to the
mos oncogene, are required to induce the MPSV pathology
(3, 14, 15), the target cell of MPSV has not been identified.
The present work was designed to test if MPSV infection
of lymphocytes would result in detectable alterations that
would implicate these cells as the target cell of the MPSV
pathology. Specifically, we asked: (a) whether growth prop-
erties and requirements of MPSVinfected lymphocytes are
altered; (b) whether infected lymphocytes release growth factors
constitutively or demonstrate an altered induction pattern
compared with uninfected or control virus-infected lympho-
cytes; and (c) whether the U3 region of the MPSV LTR or
the mos oncogene is required for any biological response ob-
served. For this purpose, we infected three T cell lines that
have different requirements for continued proliferation: one
for IIr2, another one for IIr2 and an undefined interaction
with splenic feeder cells, and a third with requirements for
1172 and TCR stimulation.
The requirement for the lymphocytic growth factor IIr2
was unaltered in all of the three infected T cell lines regard-
less of whether the mos oncogene was present in the viral
vector. Moreover, the dose response to IIr2 was unaltered.
This finding is in contrast to many reports ofother oncogenes
that abrogate exogenous growth factor requirement or alter
relative growth factor requirements in factor-dependent my-
eloid (32-35) or lymphoid cell lines (36, 37). Our results
here are, however, consistent with our previous observations
that the mos oncogene does not alter growth factor require-
ment of either myeloid precursor or stem cell lines (5, and
unpublished results).
The observation that neither lymphocytes nor myeloid cells
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infected with MPSV exhibited altered growth factor require-
ments would suggest that MPSV does not directly abrogate
factor dependence. Although some colony-forming cells of
MPSVinfected mice do not require growth factors to form
colonies, the number of such cells was disproportionate to
the total number ofcells plated in vitro, indicating that para-
crine or autocrine stimulation, and not direct abrogation of
growth factor requirements of infected cells, are involved in
generating the myeloproliferative disease (38).
Significantly, however, the work presented here unequivo-
callyshows that T cells infected with MPSV vectors no longer
require antigen stimulation of the TCR, or in the case of
the LB3 cell line, interaction with splenic feeder cells for long-
term proliferation. Replica plating experiments allowed analysis
on a clonal level and thus ruled out a possible outgrowth
of spontaneous secondary mutants from mass cultures. Ap-
proximately 2,000 of either MPSV vector-infected or unin-
fected control clones were analyzed. No immortalization of
uninfected clones was observed, whereas 20% of infected LB3
clones could be established as stable filler cell-independent
clones. Approximately 15% of infected E9.D4 clones estab-
lished in the replicaplating assaysurvived almost 1 yr ofweekly
transfers (46 passages) until experiments were terminated.
One effect of TCR activation is the upregulation of both
IIr2 and its receptor (39). It was therefore surprising that
the requirement for 11,2 was unchanged after MPSV infec-
tion. Thus, MPSVinfected lymphocytes must express IIr2Rs
at sufficient levels to ensure prolonged proliferation when
stimulated with IIr2. Interestingly, we also did not detect
any changes in the constitutive or induced levels of growth
factor release in any of the T cell lines infected with either
the MPSV or Mo-MuLV vectors compared with uninfected
controls. Thus, the two TCR-dependent responses, mitogen-
esis and growth factor induction, have been uncoupled.
Quite unexpectedly, the mos oncogene was not necessary
for stimulation-independent growth of infected cells, although
it has been proven to be essential for the effect of MPSV in
vivo. The continued growth without weekly stimulation of
both LB3 and E9.D4 cells infected with the neon/mos -
control vector was equally efficient as in cells infected with
neon MPSV
However, consistent with previous results on other cells
and on in vivo generation of myeloproliferative disease, se-
quences within the U3 region ofthe MPSV LTR are required
for the altered growth requirements of infected lymphocytes.
Exchange ofthe U3 region by Mo-MuLV sequences does not
permit long-term propagation of the CD4+ T cell lines
without filler cell stimulation. Neither MOV/mos'-LB3-
no ZipneoR-infected E9.D4 cells survived the replica plating
assay, disappearing with similar kinetics to the uninfected
control cells.
By what mechanism do vectors containing the MPSV U3
LTR region, but not necessarily the mos oncogene, abrogate
the requirement for filler cell stimulation? One could envisage
that regulatory sequences within the U3 region act to in-
crease the transcriptional level of the proviral genome or a
gene flanking the provirus, resulting in high level expressionof a viralor cellular gene. Indeed, several studies have demon-
strated that transcription enhancement by the MPSV LTR
is more efficient than that of the Mo-MuLV LTR in several
undifferentiated and differentiated cell types (5, 7-9, and Beck-
Engeser, G. et al., manuscript submitted for publication).
Two regions of the MPSV LTR appear to be important for
this distinctive property of MPSVderived retroviral vectors:
a new SP1 binding site generated by a single point mutation
downstream of the direct repeat, and possibly several point
mutations clustered at the 5' end of the direct repeat (M.
Grez, manuscript in preparation).
The high incidence (20% of LB3 clones or >17% ofE9.D4
clones) at which the stimulation requirement was abrogated
excludes the possibility that the site of provirus integration
is important, as the infection protocol (MOI <1) was de-
signed to ensure no more than one retroviral copy per ge-
nome, and this was confirmed by Southern blot analysis of
infected LB3 clones (data not shown). This rules out the con-
tribution of host sequences, but leaves the possibility that
viral-encoded proteins may contribute to the altered stimula-
tion requirement.
Two genes, neon and gag, are known to be expressed by
both neon MPSV and neon/mos- . However, it is unlikely
that they are responsible for the loss of stimulation require-
ment. An enhanced expression of the gene under G418 selec-
tion would result in better survival of infected clones in the
replica plating assay. Our data, however, clearly demonstrate
that clones survive better when maintained without selec-
tive pressure (Fig. 5). Moreover, the lack of a difference in
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Influence of G418 selection on growth of infected cells.
Replica plating assay of MPSVinfected E9.134 clones. Clones were
obtained from primary infection plates and maintained as described in
Fig. 3. After the first transfer, positive wells were split and main-
tained with (filled symbols) or without (open symbols) G418. Mock-
infected E9.D4 clones (O, n - 527); neon MPSV-infected E9.D4
clones (A, n = 581); neon MPSV mos- -infected E9.134 clones (D,
n = 384).
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the efficiency of expressed gene transfer (neoncolonies, Table
1) on infection with vectors with the Mo-MuLV U3 region
compared with those infected containing the MPSV U3 re-
gion would strongly suggest that the level of expression of
the viral transcript is not directly involved in abrogating the
indicated growth requirements ofthese T cell lines, since we
and others have demonstrated that differential transcription
rates of Mo-MuLV or MPSV vectors usually reflect different
efficiencies of recovering G418-resistant colonies (5, 30).
Immunoprecipitation using anti-p30, anti-p15, and anti-
p12 has indicated that a gag-related protein of 62-65 kD is
translated from the full-length RNA of the MPSV viral ge-
nome. Pulse-chase and Western blot analysis of the MPSV
gag precursors indicated that they are intracellularly stable
and do not give rise to mature virion proteins (40). The hy-
pothesis that gag precursor proteins interfere with stimula-
tion pathways in infected target cells, however, can probably
be ruled out, since infection with the MOV/mos- construct
with the identical coding region does not result in abroga-
tion of the stimulation requirement.
Another transforming mechanism by sequences within the
MPSV U3 LTR may involve competition for factors that alter
the expression ofa cellular gene that is involved in the mito-
genic response of activated T cells. Sequence analysis of the
unique U3 region has revealed recognition sequences for sev-
eral transcription factors, including a unique SP1 binding site
(9, and M. Grez, manuscript in preparation). However, it
is difficult to imagine a mechanism in which a single viral
copy per cellular genome could effectively alter the distribu-
tion ofproteins involved in gene regulation. Factors that regu-
late transcription and translation by binding RNA are poorly
understood, but it cannot be excluded that these may play
a role in the MPSVinduced "transformation" oflymphocytes.
We report here a unique mechanism by which the stimu-
lation requirement of T cell lines is abrogated. This is in
striking contrast to the long observed involvement of retro-
viruses in human adult T cell leukemia (41-43), in which
autocrine IL-2 stimulation and/or lymphokine expression can
be linked to the trans-activator protein p40X encoded by the
HTLVI genome. The p40x (or tax) protein can bind to its
own viral LTR and thus enhance retroviraltranscription, but
it binds as well to distinct sequences in the 5' flanking regions
of the IL2 and IL-2R genes, thus, trans-activating gene ex-
pression. Moreover, it was demonstrated that mitogen-induced
activation of 11,2 and IL2R geneswas mediated via the same
binding sites and was coupled with p40x activation (44).
Furthermore, B6hnlein et al. (45) have reported sequence ho-
mology between the HTLVI LTR and the IL2ot receptor
gene, both ofwhich are regulated by the same nuclear binding
proteins. The MPSVbased vectors, however, contain no known
coding region for a putative trans-activating protein and do
not induce IL-2 expression.
Taken together, the effect of MPSV infection of represen-
tative T cell lines does not easily explain the transforming
potential of MPSV in vivo. Our results, however, provide
evidence that MPSVinfected T cells might have a prolifera-
tive advantage over uninfected cells in vivo. These cells mayno longer depend on TCItspecific activation for clonal ex-
pansion. More T cells would then be available to respond
to antigenic stimulation and secrete lymphokines. The role
of the mos oncogene in the induction of the myeloprolifera-
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